Literature DB >> 16206074

Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progression.

Eric S Daar1, Henry S Lynn, Sharyne M Donfield, Alice Lail, Stephen J O'Brien, Wei Huang, Cheryl A Winkler.   

Abstract

This study used a well characterized cohort of human immunodeficiency virus type 1 (HIV-1)-infected hemophiliacs to define the relationship between the SDF1-3'A allele, the plasma HIV-1 coreceptor tropism, and the natural history of HIV-1 disease. Subjects heterozygous or homozygous for the SDF1-3'A allele experienced higher rates of decline in CD4+ T cell counts over time than did those without the allele (P=.009). Moreover, they had an increased risk of progression to acquired immunodeficiency syndrome and death, a relationship that persisted even when baseline plasma HIV-1 RNA levels and CD4+ T cell counts or CCR5 Delta 32 and CCR2-64I genotype were controlled for. This relationship was even stronger in a subgroup of subjects for whom tropism data were available. Subjects with the SDF1-3'A allele were also more likely to have detectable X4-tropic viruses (P=.012), and, when tropism was included in the survival analyses, the effect of the SDF1-3'A allele on disease progression was no longer significant. Therefore, the increased frequency of X4-tropic viruses in subjects carrying the SDF1-3'A allele may explain the observed adverse effect that this allele has on the natural history of HIV-1 disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16206074     DOI: 10.1086/496893

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Novel antiretroviral agents in HIV therapy.

Authors:  Caitlin Reed; Eric S Daar
Journal:  Curr Infect Dis Rep       Date:  2006-11       Impact factor: 3.725

2.  The Distribution of CCR2-64I, SDF1-3'A and MCP1-2518 G/A Genes Polymorphism in a Specific High Risk Group from the Northeastern States West Bengal, and Gorkha Population in India.

Authors:  Partha Roy; Sekhar Chakrabarti
Journal:  Indian J Virol       Date:  2012-09-12

3.  CCR2, CCR5, and CXCL12 variation and HIV/AIDS in Papua New Guinea.

Authors:  Noemi B Hall; Shannon E Bruse; Bangan John; Rajeev K Mehlotra; Melinda J Blood Zikursh; Catherine M Stein; Peter M Siba; Peter A Zimmerman
Journal:  Infect Genet Evol       Date:  2015-09-28       Impact factor: 3.342

4.  Association of host genetic risk factors with the course of cytomegalovirus retinitis in patients infected with human immunodeficiency virus.

Authors:  Efe Sezgin; Mark L van Natta; Alka Ahuja; Alice Lyon; Sunil Srivastava; Jennifer L Troyer; Stephen J O'Brien; Douglas A Jabs
Journal:  Am J Ophthalmol       Date:  2011-03-10       Impact factor: 5.258

5.  Host genetic influences on highly active antiretroviral therapy efficacy and AIDS-free survival.

Authors:  Sher L Hendrickson; Lisa P Jacobson; George W Nelson; John P Phair; James Lautenberger; Randall C Johnson; Lawrence Kingsley; Joseph B Margolick; Roger Detels; James J Goedert; Stephen J O'Brien
Journal:  J Acquir Immune Defic Syndr       Date:  2008-07-01       Impact factor: 3.731

6.  Relationship between HIV coreceptor tropism and disease progression in persons with untreated chronic HIV infection.

Authors:  Matthew Bidwell Goetz; Robert Leduc; Jay R Kostman; Ann M Labriola; Yolanda Lie; Jodi Weidler; Eoin Coakley; Michael Bates; Roberta Luskin-Hawk
Journal:  J Acquir Immune Defic Syndr       Date:  2009-03-01       Impact factor: 3.731

7.  HIV Co-receptor usage in HIV-related non-hodgkin's lymphoma.

Authors:  Erin Reid; Sheldon R Morris
Journal:  Infect Agent Cancer       Date:  2012-03-15       Impact factor: 2.965

8.  Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study.

Authors:  Timothy J Henrich; Paul J McLaren; Suhas S P Rao; Nina H Lin; Emily Hanhauser; Francoise Giguel; Roy M Gulick; Heather Ribaudo; Paul I W de Bakker; Daniel R Kuritzkes
Journal:  Open Forum Infect Dis       Date:  2014-05-22       Impact factor: 3.835

9.  The role of genetic variants of Stromal cell-Derived Factor 1 in pediatric HIV-1 infection and disease progression.

Authors:  Ketty Gianesin; Riccardo Freguja; Francesco Carmona; Marisa Zanchetta; Paola Del Bianco; Sandro Malacrida; Marco Montagna; Osvalda Rampon; Carlo Giaquinto; Anita De Rossi
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

10.  Predictors of disease progression in HIV infection: a review.

Authors:  Simone E Langford; Jintanat Ananworanich; David A Cooper
Journal:  AIDS Res Ther       Date:  2007-05-14       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.